BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18677559)

  • 1. Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas.
    Wargon V; Helguero LA; Bolado J; Rojas P; Novaro V; Molinolo A; Lanari C
    Breast Cancer Res Treat; 2009 Aug; 116(3):449-60. PubMed ID: 18677559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas.
    Wargon V; Fernandez SV; Goin M; Giulianelli S; Russo J; Lanari C
    Breast Cancer Res Treat; 2011 Apr; 126(2):319-32. PubMed ID: 20440553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins.
    Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA
    Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear progesterone receptor A and B isoforms in mouse fallopian tube and uterus: implications for expression, regulation, and cellular function.
    Shao R; Weijdegård B; Ljungström K; Friberg A; Zhu C; Wang X; Zhu Y; Fernandez-Rodriguez J; Egecioglu E; Rung E; Billig H
    Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E59-72. PubMed ID: 16449295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen or antiprogestin treatment induces complete regression of pulmonary and axillary metastases in an experimental model of breast cancer progression.
    Vanzulli SI; Soldati R; Meiss R; Colombo L; Molinolo AA; Lanari C
    Carcinogenesis; 2005 Jun; 26(6):1055-63. PubMed ID: 15774491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progesterone receptor involvement in independent tumor growth in MPA-induced murine mammary adenocarcinomas.
    Montecchia MF; Lamb C; Molinolo AA; Luthy IA; Pazos P; Charreau E; Vanzulli S; Lanari C
    J Steroid Biochem Mol Biol; 1999 Jan; 68(1-2):11-21. PubMed ID: 10215033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.
    Lamb CA; Fabris V; Gorostiaga MA; Helguero LA; Efeyan A; Bottino MC; Simian M; Soldati R; Sanjuan N; Molinolo A; Lanari C
    J Cell Physiol; 2005 Mar; 202(3):672-82. PubMed ID: 15389583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
    Wargon V; Riggio M; Giulianelli S; Sequeira GR; Rojas P; May M; Polo ML; Gorostiaga MA; Jacobsen B; Molinolo A; Novaro V; Lanari C
    Int J Cancer; 2015 Jun; 136(11):2680-92. PubMed ID: 25363551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Inhibitive effects of mifepristone on growth of breast cancer: experiment with animal model].
    Tian XS; Zhou WH; Wu GJ; Sun JZ; Cong MH
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):559-63. PubMed ID: 18649774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of pregnancy-dependent mouse mammary tumors after long dormancy periods. Involvement of Wnt pathway activation.
    Gattelli A; Cirio MC; Quaglino A; Schere-Levy C; Martinez N; Binaghi M; Meiss RP; Castilla LH; Kordon EC
    Cancer Res; 2004 Aug; 64(15):5193-9. PubMed ID: 15289324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
    Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M
    Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.
    Simian M; Manzur T; Rodriguez V; de Kier Joffé EB; Klein S
    Breast Cancer Res Treat; 2009 Jan; 113(1):1-8. PubMed ID: 18183485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane-initiated effects of progesterone on proliferation and activation of VEGF in breast cancer cells.
    Neubauer H; Adam G; Seeger H; Mueck AO; Solomayer E; Wallwiener D; Cahill MA; Fehm T
    Climacteric; 2009 Jun; 12(3):230-9. PubMed ID: 19340614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of estrogen-resistance in murine mammary adenocarcinomas.
    Montecchia MF; Molinolo A; Lanari C
    Breast Cancer Res Treat; 1999 Mar; 54(2):93-9. PubMed ID: 10424399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
    Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
    Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs).
    Wardell SE; Edwards DP
    Semin Reprod Med; 2005 Feb; 23(1):9-21. PubMed ID: 15714386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of epidermal growth factor receptor inhibitor alone and in combination with cisplatin on growth of vulvar cancer cells.
    Kim SH; Song YC; Kim SH; Jo H; Song YS
    Ann N Y Acad Sci; 2009 Aug; 1171():642-8. PubMed ID: 19723115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
    Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
    J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activities of progesterone receptor isoform A and B are differentially modulated by their ligands in a gene-selective manner.
    Leo JC; Lin VC
    Int J Cancer; 2008 Jan; 122(1):230-43. PubMed ID: 17893877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.